Sidrônio Maria Gabriella S, Freitas Maria Eugênia G, Magalhães Daniel W A, Carvalho Deyse C M, Gonçalves Vinícius A B, Oliveira Ana Caroline M de Queiroz, Paulino Gisela C, Borges Gabriela C, Ribeiro Rafaelle L, Sousa Natália Ferreira de, Scotti Marcus T, Araújo Demétrius A M de, Mendonça-Junior Francisco Jaime B, Freire Kristerson R de Luna, Rodrigues-Mascarenhas Sandra, Santos Bárbara Viviana de O, Rodrigues-Junior Valnês S
Postgraduate Program in Development and Technological Innovation in Medicines, Federal University of Paraíba (UFPB), João Pessoa 58051-900, PB, Brazil.
Laboratory of Biotechnology in Microorganisms, Biotechnology Center, Federal University of Paraíba (UFPB), João Pessoa 58051-900, PB, Brazil.
Microorganisms. 2025 Mar 1;13(3):561. doi: 10.3390/microorganisms13030561.
Caulerpin, a bis-indole alkaloid isolated from , has several documented pharmacological activities, including antineoplastic and antiviral properties. This study aimed to evaluate the anti-inflammatory and anti-tubercular potentials of caulerpin and its analogues in RAW 264.7 macrophages infected with spp. Additionally, we evaluated cytokine production and NLRP3 expression in this infection model. Toxicity tests were performed using Vero E6 and HepG2 cell lines and . Pre-incubation of RAW 264.7 cells with caulerpin and its analogues decreased internalized and H37Ra. Furthermore, treatment of -infected macrophages with caulerpin and its analogues reduced bacterial loads. Caulerpin reduced the CFU count of internalized bacilli in the H37Ra infection model. In addition, caulerpin and its diethyl derivative were notably found to modulate IL-1β and TNF-α production in the infection model after quantifying pro-inflammatory cytokines and NLRP3. Caulerpin and its derivates did not affect the viability of Vero E6 and HepG2 cell lines or nauplii survival in toxicity studies. These findings demonstrate that caulerpin and its analogues exhibit anti-inflammatory activity against spp. infection in RAW 264.7 macrophages and show promising potential for further efficacy and safety evaluation.
从[未提及的来源]中分离出的双吲哚生物碱卡勒平具有多种已记录的药理活性,包括抗肿瘤和抗病毒特性。本研究旨在评估卡勒平和其类似物在感染[未提及的菌种]的RAW 264.7巨噬细胞中的抗炎和抗结核潜力。此外,我们在该感染模型中评估了细胞因子的产生和NLRP3的表达。使用Vero E6和HepG2细胞系以及[未提及的内容]进行了毒性测试。用卡勒平和其类似物对RAW 264.7细胞进行预孵育可减少内化的[未提及的内容]和H37Ra。此外,用卡勒平和其类似物处理感染[未提及的菌种]的巨噬细胞可降低细菌载量。在H37Ra感染模型中,卡勒平降低了内化杆菌的CFU计数。此外,在对促炎细胞因子和NLRP3进行定量后,特别发现卡勒平和其二乙基衍生物在[未提及的感染]模型中可调节IL-1β和TNF-α的产生。在毒性研究中,卡勒平和其衍生物不影响Vero E6和HepG2细胞系的活力或无节幼体的存活。这些发现表明,卡勒平和其类似物在RAW 264.7巨噬细胞中对[未提及的菌种]感染具有抗炎活性,并显示出进一步进行疗效和安全性评估的有前景的潜力。